STUDIES ON THE FLEXNER GROUP OF DYSENTERY BACILLI
Open Access
- 1 April 1945
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 81 (4) , 349-358
- https://doi.org/10.1084/jem.81.4.349
Abstract
The purified specific antigen of Type V S. paradysenteriae was administered intracut. to a group of 19 volunteers. The sera of the subjects obtained 3 weeks following the course of inoculations showed agglutinins for the homologous Type V microorganism in high titre as well as agglutinins in lower titre for heterologous Flexner types. The pooled sera showed a 10-fold increase in homologous mouse protective antibodies and a 2-fold increase against a heterologous Type Z micro-organism. 2.5 [gamma] of antigen is a safe initial dose. This amt. gives rise to a moderate local reaction, but in no instance to systemic reactions. The optimum immunization schedule appears to be 2.5, 7.5 and 15 [gamma] of antigen given at weekly intervals. Prolonged immunization does not increase the antibody response, nor will it increase the tolerance of the individual to a dose of antigen 25 [gamma]. Sera obtained after 6 months showed but a slight fall in agglutinin titre which could be reestablished with a small recall dose. The purified polysaccharide hapten of the Type V antigen was also administered to a small group of volunteers in a single dose of 50 or 100 [gamma]. Only 2 of the individuals responded with an increase in bacterial agglutinins. The more potent serum was found to contain a 3-fold increase in mouse protective antibodies. The practical aspects of large scale prophylactic immunization are discussed.This publication has 10 references indexed in Scilit:
- Enteric Group Fevers in Prisoners from the Western DesertBMJ, 1943
- Military Medicine in the Middle EastBMJ, 1943
- Studies in immunochemistryBiochemical Journal, 1940
- Typhoid Endotoxoid VaccineBMJ, 1939
- Bacterial AntigensNature, 1939
- Ketene (CH 2 =CO): A New Reagent for the Detoxification of VaccineScience, 1936
- SPECIFIC ANTIBODY RESPONSE OF HUMAN SUBJECTS TO INTRACUTANEOUS INJECTION OF PNEUMOCOCCUS PRODUCTSThe Journal of Experimental Medicine, 1932
- SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIAThe Journal of Experimental Medicine, 1931
- CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDEThe Journal of Experimental Medicine, 1930
- AN EXPERIMENTAL STUDY OF VACCINATION AGAINST BACILLI DYSENTERIÆThe Journal of Experimental Medicine, 1918